Unternehmensübersicht
SRx Health Solutions Inc. (SRXH) operates within the consumer defensive sector, specifically the packaged foods industry, through its subsidiaries which engage in specialty pharmacy and pet health and wellness businesses across the United States, Taiwan, and international markets. The company's product portfolio includes pet health and wellness products available in multiple forms, such as kibble, canned food, and freeze-dried raw food. This entity is a micro-cap enterprise with a market capitalization of $48.11 million, supported by an annual revenue of $9.34 million and a workforce comprising 10 employees. These financial metrics indicate that the company occupies a very small position in the broader market, reflecting a nascent scale that is typical for early-stage or niche specialty players where revenue generation is limited relative to larger, established peers in the consumer goods sector. The combination of a market cap under $50 million and a single-digit employee count suggests that the business model relies on highly specialized operations rather than broad-scale distribution networks.
Finanzielle Gesundheit
The company reported a trailing twelve-month revenue of $9.34 million, yet this top-line figure is contrasted by a net income of $-17,253,000, revealing a severe disconnect where operating costs and expenses significantly exceed total revenue generation. EBITDA stands at $-12,770,000, further confirming that the core business operations are generating negative cash earnings before interest, taxes, depreciation, and amortization. Since free cash flow data is not available, the company's ability to fund capital expenditures without external financing remains uncertain, indicating a potential lack of financial flexibility for reinvestment or debt servicing. The gross margin is calculated at 27.6%, which provides a baseline profitability on sales before overhead, yet the operating margin is a staggering -135.0%, signifying that operating expenses are more than double the revenue, while the profit margin is listed at 0.0%. On the liquidity side, the company holds $13.06 million in cash against total debt of $21.03 million, resulting in a debt-to-equity ratio of 596.71, which characterizes the balance sheet as highly leveraged and potentially vulnerable to interest rate fluctuations. The current ratio of 0.80 indicates that current assets are insufficient to cover current liabilities, pointing to potential short-term liquidity constraints. Return on equity and return on assets are not available due to the negative equity position, which precludes the calculation of meaningful return metrics and obscures the assessment of management effectiveness in generating value from shareholder capital and total assets.
Bewertungsanalyse
Trailing P/E and forward P/E ratios are not available, primarily because the company reports a net loss, which prevents the calculation of a meaningful earnings-based multiple and leaves the expected earnings trajectory undefined by these specific metrics. The price-to-book ratio is -1.27, a negative multiple that indicates the market values the company at less than its book value, suggesting that the market perceives significant risks or liabilities that outweigh the recorded assets on the balance sheet. The price-to-sales ratio stands at 5.15, while the EV/EBITDA is -4.85, implying that valuing the firm based on revenue or enterprise value relative to earnings yields distorted figures that do not reflect traditional profitability benchmarks for mature firms. The stock's trading range over the past year spans from a 52-week low of $0.08 to a 52-week high of $2.02, meaning the current price sits significantly below the 52-week high, reflecting the extreme volatility and lack of sustained price momentum typical of micro-cap stocks with limited liquidity. A beta value is not available, which means that the company's price volatility relative to the broader market cannot be quantified using standard historical data.
Growth & Income
Revenue growth year-over-year and earnings growth year-over-year are not available in the provided data, preventing an analysis of whether earnings are growing faster or slower than revenue, though the negative net income suggests the company is currently in a loss-making phase rather than a growth phase. The company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which indicates that the firm retains all of its limited earnings, if any, or relies on cash reserves rather than distributing income to shareholders. Consequently, the company reinvests any available financial resources back into the business or uses them to manage its substantial debt load rather than paying dividends to investors. The overall growth and income profile is characterized by a lack of historical growth data, a complete absence of dividend income, and a reliance on cash reserves to offset negative earnings and high leverage.